Evidence map›Paper›PMID 29899144›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase.

Kristian K Kristensen, Søren Roi Midtgaard, Simon Mysling, Oleg Kovrov, Lars Bo Hansen, Nicholas Skar-Gislinge, Anne P Beigneux, Birthe B Kragelund, Gunilla Olivecrona, Stephen G Young and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 65 citations in OpenAlex.

  1. GPIHBP1 on oligodendrocytes binds lipoprotein lipase within the human brain.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. ANGPTL3/8 is an atypical unfoldase that regulates intravascular lipolysis by catalyzing unfolding of lipoprotein lipase.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Review
  9. Article
  10. Review
  11. HumanOncotarget · 2023
    Article
  12. Inverse effects of APOC2 and ANGPTL4 on the conformational dynamics of lid-anchoring structures in lipoprotein lipase.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. A protein of capillary endothelial cells, GPIHBP1, is crucial for plasma triglyceride metabolism.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Kristian K KristensenFinsen Laboratory, Rigshospitalet, DK-2200 Copenhagen N, Denmark.
Søren Roi MidtgaardStructural Biophysics, Niels Bohr Institute, University of Copenhagen, DK-2100 Copenhagen Ø, Denmark.
Simon MyslingFinsen Laboratory, Rigshospitalet, DK-2200 Copenhagen N, Denmark.
Oleg KovrovDepartment of Medical Biosciences, Umeå University, SE-901 87 Umeå, Sweden.
Lars Bo HansenZealand Pharma, DK-2600 Glostrup, Denmark.
Nicholas Skar-GislingeStructural Biophysics, Niels Bohr Institute, University of Copenhagen, DK-2100 Copenhagen Ø, Denmark.
Anne P BeigneuxDepartment of Medicine, University of California, Los Angeles, CA 90095.
Birthe B KragelundDepartment of Biology, University of Copenhagen, DK-2200 Copenhagen N, Denmark.
Gunilla OlivecronaDepartment of Medical Biosciences, Umeå University, SE-901 87 Umeå, Sweden.
Stephen G YoungDepartment of Medicine, University of California, Los Angeles, CA 90095; sgyoung@mednet.ucla.edu m-ploug@finsenlab.dk.
Thomas J D JørgensenDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense M, Denmark.
Loren G FongDepartment of Medicine, University of California, Los Angeles, CA 90095.
Michael PlougFinsen Laboratory, Rigshospitalet, DK-2200 Copenhagen N, Denmark; sgyoung@mednet.ucla.edu m-ploug@finsenlab.dk.ORCID 0000-0003-2215-4265
University of Copenhagen · DKUniversity of California, Los Angeles · USUmeå University · SEUniversity of Southern Denmark · DKZealand Pharma (Denmark) · DK

Funding

The Lipin Protein Family and Triglyceride Metabolism P01HL090553 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2008 to 2018
$23.3M
Understanding the Influence of Lipid Homeostasis on T cell FunctionP01HL146358 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TONTONOZ, PETER J · 2019 to 2023
$11.7M
Refining Physiologic Mechanisms for Intravascular Triglyceride MetabolismR01HL087228 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEIGNEUX, ANNE, FONG, LOREN GI · 2007 to 2024
$7.8M
Investigating Mechanisms for Lipid Transport in Health and DiseaseR35HL139725 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2018 to 2024
$6.1M
Defining mechanisms for lipid transport across capillary endothelial cellsR01HL125335 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2015 to 2017
$1.2M
NHLBI NIH HHS P01 HL090553NHLBI NIH HHS P01 HL146358NHLBI NIH HHS R01 HL087228NHLBI NIH HHS R01 HL125335NHLBI NIH HHS R35 HL139725
6 · The paper itself

Abstract

The intravascular processing of triglyceride-rich lipoproteins depends on lipoprotein lipase (LPL) and GPIHBP1, a membrane protein of endothelial cells that binds LPL within the subendothelial spaces and shuttles it to the capillary lumen. In the absence of GPIHBP1, LPL remains mislocalized within the subendothelial spaces, causing severe hypertriglyceridemia (chylomicronemia). The N-terminal domain of GPIHBP1, an intrinsically disordered region (IDR) rich in acidic residues, is important for stabilizing LPL's catalytic domain against spontaneous and ANGPTL4-catalyzed unfolding. Here, we define several important properties of GPIHBP1's IDR. First, a conserved tyrosine in the middle of the IDR is posttranslationally modified by O-sulfation; this modification increases both the affinity of GPIHBP1-LPL interactions and the ability of GPIHBP1 to protect LPL against ANGPTL4-catalyzed unfolding. Second, the acidic IDR of GPIHBP1 increases the probability of a GPIHBP1-LPL encounter via electrostatic steering, increasing the association rate constant (

Indexed as

Angiopoietin-Like Protein 4AnimalsEndothelial CellsHumansHyperlipoproteinemia Type ILipoprotein LipaseMiceProtein BindingProtein DomainsReceptors, LipoproteinTyrosineAngiopoietin-Like Protein 4ANGPTL4 protein, humanAngptl4 protein, mouseGPIHBP1 protein, humanGPI-HBP1 protein, mouseLipoprotein LipaseLPL protein, humanReceptors, LipoproteinTyrosineautoimmune diseaseelectrostatic steeringhypertriglyceridemiaintravascular lipolysisintrinsically disordered region

Identifiers

PMID29899144
PMCPMC6042107
OpenAlexW2807853241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.